Crossmark

Rebalancing the inflammatory trajectory from inflammatory bowel disease to colitis-associated colorectal cancer via artemisinin-based multitarget therapy

Crossref DOI link: https://doi.org/10.1038/s41401-025-01747-9

Published Online: 2026-02-05

Published Print: 2026-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

He, Shi-jun https://orcid.org/0000-0002-9207-3631
Tang, Mei-lin https://orcid.org/0009-0004-7957-3609
Chen, Li https://orcid.org/0009-0003-4040-1028
Zuo, Jian-ping https://orcid.org/0000-0002-0900-9568
Xu, Han-chen https://orcid.org/0000-0003-0441-7500
Lin, Ze-min https://orcid.org/0000-0002-3665-874X
License Information

Text and Data Mining valid from 2026-02-05

Version of Record valid from 2026-02-05
More Information

Article History

Received: 18 September 2025

Accepted: 26 December 2025

First Online: 5 February 2026

Competing interests

: Prof Jian-ping ZUO is the one of the Associate Editors of the journal and was not involved in the peer review or the decision making of the article. The authors declare no other competing interests.

Document is current

Any future updates will be listed below